期刊文献+

局限期小细胞肺癌化疗联合胸腔放疗的疗效分析

Efficacy of Limited Small Cell Lung Cancer Chemotherapy Combined with Thoracic Radiotherapy
下载PDF
导出
摘要 目的探究局限期小细胞肺癌化疗联合胸腔放疗的疗效。方法随机选取2013年3月—2014年3月这1年间在该院进行治疗的局限期小细胞癌患者100名,随机分为两组,每组50人,观察组患者采用化疗联合胸腔放疗的方法进行治疗,对照组患者单纯采用化疗的方法进行治疗,观察两组患者的恢复情况。结果观察组患者完全缓解的有40人,部分缓解的有6人,转移的有4人,治疗有效率为92%;对照组患者完全缓解的有25人,部分缓解的有10人,转移的有15人,治疗有效率为70%,两组患者在治疗有效率上比较(χ2=4.237,P=0.034),差异有统计学意义(P<0.05)。结论采用化疗联合胸腔放疗的方法治疗局限期小细胞癌的疗效优于单纯的采用化疗进行治疗。 Objective To explore the limited small cell lung cancer chemotherapy combined with thoracic radiotherapy. Methods From March 2013 to March 2014, selected 100 patients in our hospital for treatment of limited small cell carcinoma. They were randomly divided into two groups on average. The observation group was treated with chemotherapy and thoracic radiotherapy methods of treatment, while patients in the control group using the method of chemotherapy alone for treatment. Recovery was observed in the two groups of patients. Results The patients in the observation group with complete remission of 40 people, partial remission of six people, the transfer of four people, the effective rate was 92%; The control group, 25 patients were in complete remission, partial remission of 10 people, and there are 15 people transfer, the effective rate of 70%. Comparing two groups of patients in treatment efficiency(χ^2=4.237,P =0.034), the results were statistically significant(P〈0.05). Conclusion The use of chemotherapy combined with thoracic radiotherapy method of treatment for limited small cell carcinoma more effective than chemotherapy alone for treatment.
作者 薛峰
出处 《中外医疗》 2015年第22期23-24,共2页 China & Foreign Medical Treatment
关键词 小细胞肺癌 NSE 预后 生存 Small cell lungcaner NSE The prognosis Existence
  • 相关文献

参考文献8

  • 1Huncharek M, MeGarry R. A meta-analysis of the timing of chest irradi- ation in the combined modality treatment of limited-stage small cell lung cancer[J].Oncologist,2014,9(6):665-672.
  • 2Bremnes R M, Sundstrom S, Vilsvik J, et al. Multicenter phase Ⅱ trial of paclitaxel, cisplatin, and etoposide with concurrent ra-diation for limit- ed-stage smal-1 cell lung cancer[J].J Clin 0ncol,2001,19(15):3532-3538.
  • 3蒋华勇,郑明民,许卫东,高军茅,姚波.调强放疗联合化疗治疗局限期小细胞肺癌近期疗效分析[J].现代肿瘤医学,2011,19(9):1753-1755. 被引量:3
  • 4陈桂园,王丽娟,蒋国樑,钱浩,傅小龙,赵森,丁琳.化放疗综合治疗95例局限期小细胞肺癌的疗效分析[J].中国肺癌杂志,2000,3(5):340-343. 被引量:6
  • 5巩合义,赵文元,孙洪福,黄伟,和劲光,伊艳,李宝生.局限期小细胞肺癌三维适形放疗及同步化疗的临床研究[J].中华放射肿瘤学杂志,2010,19(3):205-208. 被引量:15
  • 6Saijo N. Progress in treatmem of small cell lung cancer, role ofCPT-1 1[J]. Br J Cancer,2013,89(12):2178-2183.
  • 7JemalA,MurrayT,WardE,et al.Cancer statisties,2014.CA Cancer J Clin, 2014,55(5):10.
  • 8NieU H B, Herndon J E, Miller A A,et al. Randomized Phase Ⅲ Inter- group Trial of Etoposide and Cisplatin With or Without Pa-clitaxel and Granulocyte Colony-Stimulating Factor in Patients With Extensive- Stage Smal-1 Cell Lung Cancer: Cancer and Leukemia Group B Trial 9732[J].J Clin 0ncol,2005,23(16):3752-3759.

二级参考文献19

  • 1于金明,任瑞美,袁明智,尹勇,岳金波.早期非小细胞肺癌三维适形放疗剂量分割研究[J].中华放射肿瘤学杂志,2005,14(3):158-161. 被引量:29
  • 2王颖杰,王绿化,陈东福,周宗玫,欧广飞,梁军,张可,殷蔚伯.小细胞肺癌的三维适形放射治疗[J].中华肿瘤杂志,2005,27(9):570-572. 被引量:12
  • 3Socinski MA,Bngart JA.Limited-stage small-cell lung cancer:the current status of combined-modality therapy.J Clin Oncol,2007,25:4137-4145.
  • 4Ettinger DS,Berkey BA,Abrams RA,et al.Study of paclitaxel,etoposide and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer:a radiation therapy oncology group 9609 phase Ⅱ study.J Clin Oncol,2005,23:4991-4998.
  • 5Erridge SC,Murray N.Thoracic radiotherapy for limited-stage small cell lung cancer:issues of timing,volume,doses,and fraction.Semin Oncol,2003,30:26-37.
  • 6Mohan A,Goyal A,Singh P,et al.Survival in small cell lung cancer in India:prognostic utility of clinical features,laboratory parameters and response to treatment.Indian J Cancer,2006,43:67-74.
  • 7De Ruysscher D,Bremer BH,Koppe F,et al.Omission of elective node irradiation on basis of CT-scans in patients with limited disease small cell lung cancer:a phase Ⅱ trial.Radiother Oncol,2006,80:307-312.
  • 8Bass P,Belderbos JS,Senan S,et al.Concurrent chemotherapy (carboplatin,paclitaxel,etoposide) and involved-field radiotherapy in limited stage small cell lung cancer:a Dutch multicenter phase Ⅱ study.Br J Cancer,2006,94:625-630.
  • 9Chen GY,Jiang GL,Wang LJ,et al.Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer:a clinical phase Ⅱ trial.Int J Radiat Oncol Biol Phys,2005,61:70-75.
  • 10Komaki R,Swann RS,Ettinger DS,et al.Phase Ⅰ study of thoracic radiation dose escalation with concurrent chemotherapy for patients with limited small cell lung cancer:report of radiation therapy oncolngy group (RTOG) protocol 97-12.Int J Radiat Oncol Biol Phys,2005,62:342-350.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部